We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Knowledge and Competence Support Platform Improves POC Testing

By LabMedica International staff writers
Posted on 10 Feb 2009
A knowledge and competence support platform is designed to improve and test user competency in point-of-care (POC) testing through online courses and examination. More...


POC is a growing field and is increasingly governed by regulatory requirements including competence assessment and training on a regular basis. Training in many countries is emerging as a compulsory expectation in POC management.

Continuous quality assurance of POC means ongoing recertification of standards. The Cobas academy is suitable for providing courses and exams for recertification to large numbers of staff. Knowledgeable and competent end users can deliver better use and greater reliability of POC devices, fewer errors in each of the analytic stages, and more appropriate use of lab resources.

Cobas academy's primary function is to test user competency after the initial face-to-face training. Accessible on the hospital intranet, it offers the user an optional pre-test that generates a study plan to focus only on required areas. The platform offers greater flexibility in training delivery and the opportunity to involve a larger group of staff.

Roche Diagnostics (Rotkreuz, Switzerland) launched the new knowledge and competence support platform, which currently offers three courses cobas b 221, Accu-Chek Inform, and Accu-Chek Inform II. Cobas academy is available in countries that proffer cobas IT (information technology) 1000 solutions.

Roche is a developer of in vitro diagnostics (IVD), drugs for cancer, transplantation, and virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders, and diseases of the central nervous system (CNS).

Related Links:
Roche



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A new study identifies distinct metabolomic signatures in maternal blood associated with both the timing and type of early birth (Image credit: iStock)

Maternal Blood Biomarkers Identify Risk of Preterm and Early-Term Birth

Preterm and early-term births can lead to lasting complications because vital organs continue to mature during the final weeks of pregnancy. Babies born too soon face increased risks of breathing difficulties,... Read more

Microbiology

view channel
Image: Graphical Abstract (Emery, J. K., V. Nemidkanam, N. Colon, et al. Journal of Extracellular Vesicles (2026). https://doi.org/10.1002/jev2.70286)

Extracellular Vesicle Biomarker May Enable Noninvasive Monitoring of H. pylori

Helicobacter pylori infects an estimated 43.9% of the global population, affecting approximately 4.4 billion people worldwide. In many regions, including Africa, Eastern Europe, and Southeast Asia, prevalence... Read more

Industry

view channel
Image

QIAGEN Enhances QIAcuity Platform with Gene Expression and Multiplexing Tools

QIAGEN (Venlo, Netherlands) has introduced additions to its QIAcuity dPCR ecosystem that focus on gene expression, expanded assay content, and workflow standardization for life sciences and biopharma users.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.